InvestorsObserver
×
News Home

Wall Street's Analysis on CASI Pharmaceuticals Inc (CASI) Stock's Recent Behavior

Thursday, May 21, 2020 02:37 PM | InvestorsObserver Analysts

Mentioned in this article

Wall Street's Analysis on CASI Pharmaceuticals Inc (CASI) Stock's Recent Behavior

CASI Pharmaceuticals Inc (CASI) stock is up 47.46% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
CASI Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CASI!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With CASI Stock Today?

CASI Pharmaceuticals Inc (CASI) stock is trading at $2.61 as of 2:33 PM on Thursday, May 21, an increase of $0.15, or 6.1% from the previous closing price of $2.46. The stock has traded between $2.40 and $2.68 so far today. Volume today is high. So far 417,600 shares have traded compared to average volume of 207,501 shares.

To see the top 5 stocks in the Biotechnology industry click here.

More About CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App